Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H2N4O3.2Na |
Molecular Weight | 212.0739 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].O=C1NC2=C(NC(=O)[N-]C2=O)[N-]1
InChI
InChIKey=JNNYOCABZPYQDB-UHFFFAOYSA-L
InChI=1S/C5H4N4O3.2Na/c10-3-1-2(7-4(11)6-1)8-5(12)9-3;;/h(H4,6,7,8,9,10,11,12);;/q;2*+1/p-2
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25422986Curator's Comment: description was created based on several sources, including:
https://www.drugs.com/dict/uric-acid.html | http://www.wikidoc.org/index.php/Uric_acid
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25422986
Curator's Comment: description was created based on several sources, including:
https://www.drugs.com/dict/uric-acid.html | http://www.wikidoc.org/index.php/Uric_acid
Uric acid, generated from the metabolism of purines, has proven and emerging roles in human disease. Humans produce large quantities of uric acid. Excess serum accumulation of uric acid can lead to a type of arthritis known as gout. Hyperuricemia may increase risk factors for cardiovascular disease. High serum uric acid was associated with higher risk of type 2 diabetes and other diseases.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Urate oxidase (mammals) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2594778 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD. | 2001 Apr |
|
The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. | 2001 Apr |
|
Laryngeal manifestation of gout: a case report of a subglottic gout tophus. | 2001 Aug |
|
Uric acid or urate nephropathy? | 2001 Aug |
|
Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrations. | 2001 Aug 10 |
|
Photosensitizer initiated attacks on DNA under dry conditions and their inhibition: a DNA archiving issue. | 2001 Aug 15 |
|
Water-soluble antioxidants in human tears: effect of the collection method. | 2001 Dec |
|
Role of exercise and ascorbate on plasma antioxidant capacity in thoroughbred race horses. | 2001 Jan |
|
The role of uric acid in protection against peroxynitrite-mediated pathology. | 2001 Jan |
|
Pathways for urea production during early life of an air-breathing teleost, the African catfish Clarias gariepinus Burchell. | 2001 Jun |
|
Urate and arteriosclerosis in primary hyperparathyroidism. | 2001 Jun |
|
Evidence for alterations in circulating low-molecular-weight antioxidants and increased lipid peroxidation in smokers on hemodialysis. | 2001 Jun |
|
Renal regulation of plasma total antioxidant capacity. | 2001 Jun |
|
Cystine calculi in children: the results of a metabolic evaluation and response to medical therapy. | 2001 Jun |
|
Contribution of peroxynitrite to the beneficial effects of preconditioning on ischaemia-induced arrhythmias in rat isolated hearts. | 2001 Mar |
|
Binding of urate and caffeine to haemocyanin analysed by isothermal titration calorimetry. | 2001 Mar |
|
Uric acid and cardiovascular disease: a renal-cardiac relationship? | 2001 May |
|
Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter. | 2001 May |
|
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. | 2001 May 15 |
|
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. | 2001 Nov |
|
Isolation and characterization of the DLAD/Dlad genes, which lie head-to-head with the genes for urate oxidase. | 2001 Nov 16 |
|
Ozone causes lipid peroxidation but little antioxidant depletion in exercising and nonexercising hamsters. | 2001 Oct |
|
A family-based study of metabolic phenotypes in calcium urolithiasis. | 2001 Sep |
|
Xanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constriction in hyperhomocysteinemia: possible role of peroxynitrite. | 2002 Jan |
|
Electrosynthesis of poly-o-diaminobenzene on the Prussian Blue modified electrodes for improvement of hydrogen peroxide transducer characteristics. | 2002 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9435251
Mice: twice daily with 10 mg per dose for 7 days
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12743010
Uric acid (5 mg/dL) significantly increased MCP-1 production by rat vascular smooth muscle cells at 3, 6, and 24 hours when compared with that of control media.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
134-69-0
Created by
admin on Sat Dec 16 11:16:30 GMT 2023 , Edited by admin on Sat Dec 16 11:16:30 GMT 2023
|
PRIMARY | |||
|
73456693
Created by
admin on Sat Dec 16 11:16:30 GMT 2023 , Edited by admin on Sat Dec 16 11:16:30 GMT 2023
|
PRIMARY | |||
|
DTXSID70890495
Created by
admin on Sat Dec 16 11:16:30 GMT 2023 , Edited by admin on Sat Dec 16 11:16:30 GMT 2023
|
PRIMARY | |||
|
205-152-3
Created by
admin on Sat Dec 16 11:16:30 GMT 2023 , Edited by admin on Sat Dec 16 11:16:30 GMT 2023
|
PRIMARY | |||
|
1TX0E9ZJ0W
Created by
admin on Sat Dec 16 11:16:30 GMT 2023 , Edited by admin on Sat Dec 16 11:16:30 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD